Role of Sphingomyelin in Lipoprotein Metabolism
Role of Sphingomyelin in Lipoprotein Metabolism
批准号:
8309175
负责人:
PAPASANI V SUBBAIAH
金额:
$38.86万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2014-07-31
关键词:
AcuteAddressAffinityAgingAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntsAtherosclerosisCardiovascular DiseasesCarrier ProteinsCell membraneCell surfaceCellsCeramidesCholesterolCholesterol EstersCholesterol HomeostasisCoronary heart diseaseDataEnvironmentEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesEpidemiologic StudiesEpidemiologyEsterificationFree RadicalsFundingGenerationsGoalsHDL cholesteryl esterHeart DiseasesHumanHydrolysisHyperlipidemiaInflammationInflammatoryInflammatory ResponseLateralLeadLecithinLipaseLipid PeroxidationLipidsLipoproteinsLow-Density LipoproteinsMediatingMembraneMetabolismMolecular ChaperonesMusMyelogenousOrganellesPathway interactionsPeripheralPhasePhosphatidylcholine-Sterol O-AcyltransferasePhospholipasePhospholipidsPhysiologicalPlasmaProductionPropertyProteinsPublishingReactionRegulationReportingResistanceRiskRisk FactorsRoleSeveritiesSignaling MoleculeSphingomyelinsSterolsStructureSuperoxidesSystemTestingTherapeuticUnsaturated FatsVery low density lipoproteinWorkarachidonatebasecell growth regulationcholesterol traffickingcytokinefluidityhepatic lipasehigh density lipoprotein sphingomyelininsightlipoprotein lipasemacrophageneutrophilnew therapeutic targetnoveloxidationoxidized lipidreceptorreverse cholesterol transporttraffickinguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Sphingomyelin (SM) is the most abundant phospholipid in plasma next to phosphatidylcholine (PC), and is
an essential component of cell membrane rafts. Although recent epidemiologic studies suggest that high
SM levels in plasma increase the risk of atherosclerosis, the underlying mechanisms are unknown, because
the normal functions of SM have not been elucidated. We propose that, because of its unique structure, and
localization in the outer surface of cells, SM protects the integrity of cell membranes by inhibiting the
phospholipase and lipid peroxidation reactions. Furthermore, we propose that because of its affinity to
cholesterol, SM regulates cell cholesterol homeostasis and reverse cholesterol transport. Dysregulation of
these functions could lead to inflammation and promote atherosclerosis.
In Aim 1, we propose to test the hypothesis that SM regulates reverse cholesterol transport, focusing
on its role in the efflux of cholesterol from macrophages, and in the esterification of cholesterol by LCAT.
The novel hypothesis that SM acts as a chaperone for cholesterol during ABCG1 transporter-mediated
efflux will be explored. The role of SM in the regulation of LCAT in physiological systems will be studied. In
Aim 2, we will investigate the hypothesis that SM acts as an anti-inflammatory lipid by inhibiting the
formation of pro-inflammatory lipids such as lyso PC, arachidonate, oxidized phospholipids and oxysterols.
The hypothesis that SM competitively inhibits all enzymes that utilize PC as substrate will be tested with
respect to secretory phospholipases and endothelial lipase. The inhibitory role of SM in the generation of
pro-inflammatory oxidized PCs and oxysterols will be tested in lipoproteins and cell membranes. The effect
of SM deficiency on the macrophage and neutrophil function, including cytokine production and superoxide
generation, will be studied in myeloid-specific SM-deficient mice. In Aim 3, the role of SM and ceramide in
cellular cholesterol homeostasis will be studied by determining their effects on cholesterol trafficking
between cellular compartments and between cells and their environment. These studies will provide novel
insights into the physiological role of this important phospholipid, and could possibly identify novel
therapeutic targets against inflammation and atherosclerosis.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1021/ol9009078
发表时间:
2009-07-02
期刊:
Organic letters
影响因子:
5.2
作者:
[Lankalapalli RS, Eckelkamp JT, Sircar D, Ford DA, Subbaiah PV, Bittman R]
通讯作者:
Bittman R
DOI:
10.1016/j.freeradbiomed.2006.02.005
发表时间:
2006-06
期刊:
Free radical biology & medicine
影响因子:
7.4
作者:
[R. Sargis;P. Subbaiah]
通讯作者:
R. Sargis;P. Subbaiah
DOI:
10.1371/journal.pone.0015767
发表时间:
2011-01-19
期刊:
PloS one
影响因子:
3.7
作者:
[Luque RM, Lin Q, Córdoba-Chacón J, Subbaiah PV, Buch T, Waisman A, Vankelecom H, Kineman RD]
通讯作者:
Kineman RD
DOI:
10.1016/j.aca.2012.05.035
发表时间:
2012-07-20
期刊:
ANALYTICA CHIMICA ACTA
影响因子:
6.2
作者:
[Chen, Su, Belikova, Natalia A., Subbaiah, Papasani V.]
通讯作者:
Subbaiah, Papasani V.
DOI:
10.1016/j.chemphyslip.2011.02.002
发表时间:
2011-03
期刊:
Chemistry and physics of lipids
影响因子:
3.4
作者:
[Zhao G, Subbaiah PV, Chiu SW, Jakobsson E, Scott HL]
通讯作者:
Scott HL
共 15 条
Novel strategy to enrich brain DHA through diet: Potential application for the prevention of Alzheimer's disease
-
批准号:10454878
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Novel strategy to enrich brain DHA through diet: Potential application for the prevention of Alzheimer's disease
-
批准号:10265364
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Novel strategy to enrich brain DHA through diet: Potential application for the prevention of Alzheimer's disease
-
批准号:9922660
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Novel strategy to enrich brain DHA through diet: Potential application for the prevention of Alzheimer's disease
-
批准号:10663811
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Molecular Form of Dietary DHA and its Bioavailability for the Brain
-
批准号:8755224
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2014
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Molecular Form of Dietary DHA and its Bioavailability for the Brain
-
批准号:8900973
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2014
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Role of Membrane Modifications in the Bioactivities of Conjugated Linoleic Acids
-
批准号:8803247
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Role of Membrane Modifications in the Bioactivities of Conjugated Linoleic Acids
-
批准号:8974264
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Role of Membrane Modifications in the Bioactivities of Conjugated Linoleic Acids
-
批准号:8542103
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Role of Membrane Modifications in the Bioactivities of Conjugated Linoleic Acids
-
批准号:8727969
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Purchase of AB Sciex QTRAP 5500 System
-
批准号:8246878
-
项目类别:
-
资助金额:$43.97万
-
财政年份:2012
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Physiological Significance of Conjugated Double Bonds in Membrane Lipids
-
批准号:7529299
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2008
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Physiological Significance of Conjugated Double Bonds in Membrane Lipids
-
批准号:7651100
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2008
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM
-
批准号:6786597
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2002
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM
-
批准号:6615797
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2002
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM
-
批准号:6541430
-
项目类别:
-
资助金额:$35.13万
-
财政年份:2002
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Role of Sphingomyelin in Lipoprotein Metabolism
-
批准号:7614904
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2002
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
Role of Sphingomyelin in Lipoprotein Metabolism
-
批准号:8129759
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2002
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM
-
批准号:6943990
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2002
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM
-
批准号:7111017
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2002
-
负责人:PAPASANI V SUBBAIAH
-
依托单位:
海外基金